Alamar Biosciences, Inc Common Stock
Yahoo Finance • last month
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究
這項全國計劃會採用 Alamar Biosciences 的 NULISAseq™ Neuro 220 多重檢測組合試劑盒，分析來自 10,000 名阿茲海默症及相關認知障礙症 (ADRD) 參與者約 21,000 份的血漿樣本。 研究所得的數據集將全面開放，經由 National Alzheimer’s Coordinating Center 識別碼串聯，並藉全國數據挑戰賽，為人工智能引領的探索揭開序幕。 此計劃隸屬「透過影像技術促進 ADRD 研究清晰度聯盟」(CL... Full story
Yahoo Finance • last month
Alamar Biosciences 联合多所顶尖研究型大学推出全国性研究计划，推进神经退行性疾病血液生物标志物相关研究
这项全国性研究计划将利用 Alamar Biosciences 的 NULISAseq™ Neuro 220 检测试剂盒，对 10,000 名阿尔茨海默病及相关痴呆症 (ADRD) 受试者提供的约 21,000 万份血浆样本开展图谱分析。 生成的数据集将对外开放，可通过 National Alzheimer’s Coordinating Center (美国国家阿尔茨海默病协调中心) 编号关联调取，并依托全国数据竞赛，支持借助 AI 开展的相关探索研究。 该项目隶属于... Full story
Yahoo Finance • last month
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52... Full story
Yahoo Finance • last month
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Fremont, CA, July 13, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced a partnership with leading research universit... Full story
Yahoo Finance • last month
Alamar Biosciences 的 NULISA 數據將於 AAIC 2026 上超過 140 場科學簡報會中亮相，突顯基於血液的阿茲海默症生物標記剖析之最新進展
加州佛利蒙, July 11, 2026 (GLOBE NEWSWIRE) -- 致力推動疾病最早期檢測的精準蛋白質體學領導企業 Alamar Biosciences, Inc. (Nasdaq: ALMR) 今天宣佈，其 NULISA™ 平台將於 7 月 12 日至 15 日在倫敦舉行的阿茲海默症協會國際會議 (AAIC) 上，以超過 140 張海報及會議報告的形式亮相。如此龐大的數據量反映出 NULISA 及 ARGO™ HT 技術，在阿茲海默症和相關認知障礙症研究... Full story
Yahoo Finance • last month
AAIC 2026 逾 140 份学术报告均采用 Alamar Biosciences NULISA 数据，彰显阿尔茨海默病血液生物标志物分析领域的进展
加利福尼亚州弗里蒙特, July 11, 2026 (GLOBE NEWSWIRE) -- 致力于实现疾病最早期检测的精准蛋白质组学领域领导者 Alamar Biosciences, Inc. (Nasdaq: ALMR) 今日宣布，其 NULISA™ 平台将在 7 月 12 日至 15 日于伦敦举行的阿尔茨海默病协会国际会议 (AAIC) 上，于逾 140 份海报和会议报告中亮相。该数据量反映出研究阿尔茨海默病及相关痴呆症的科研人员已广泛采用 NULISA 和 ARG... Full story
Yahoo Finance • last month
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Fremont, CA, July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced that its NULISA™ platform will be featured... Full story
Yahoo Finance • 2 months ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood has been taking it slow with her shopping sprees lately. The co-founder, CEO, and chief investment officer at Ark Invest has been doing more selling than buying across her firm's aggressive growth exchange-traded funds (ETFs).... Full story
Yahoo Finance • 2 months ago
Alamar Biosciences 讓家居採集的指尖血液樣本，可用於靈敏度極高的多重蛋白質體分析
NULISA™ DBS 萃取試劑盒可從主流的第三方遙距採集樣本裝置收集的乾燥血點與乾燥血漿微量樣本中萃取蛋白質 此工作流程將 NULISA 的應用範圍擴展至縱向研究、去中心化研究，以及大規模族群研究 加州佛利蒙, June 04, 2026 (GLOBE NEWSWIRE) -- 致力於實現疾病最早期偵測的精準蛋白質體學頂尖機構 Alamar Biosciences, Inc. (Nasdaq: ALMR)，今天推出了 NULISA™ 乾燥血點 (DBS) 萃取試劑... Full story
Yahoo Finance • 2 months ago
Alamar Biosciences实现居家指尖采血样本适配超高灵敏度多重蛋白质组学检测
NULISA™ DBS提取试剂盒可从主流第三方远程采样设备采集的干血斑、干血浆斑微量样本中提取蛋白质 该流程将NULISA技术推广至纵向研究、去中心化研究和大规模人群研究 加利福尼亚州弗里蒙特, June 04, 2026 (GLOBE NEWSWIRE) -- 致力于尽早发现疾病的精准蛋白质组学领先企业Alamar Biosciences, Inc. (Nasdaq: ALMR) 今日推出了NULISA™干血斑 (DBS) 提取试剂盒。研究人员可使用该产品对居家采... Full story
Yahoo Finance • 3 months ago
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Lowe's(LOW) to Buy from... Full story